Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients

Eur Respir J. 2005 Jul;26(1):77-85. doi: 10.1183/09031936.05.00030805.

Abstract

The aim of the current study was to investigate the frequency, phenotype and functional activity of natural killer (NK) cells and CD56+ T-cells in the bronchoalveolar lavage fluid and peripheral blood of patients with pulmonary sarcoidosis when compared with healthy volunteers, using staining with a panel of monoclonal antibodies followed by flow cytometry. The results revealed that the majority of the lung NK cell subpopulation expressed CD56(bright). In contrast, there was a predominant CD56(dim) subset in the blood of both patients and healthy controls. Most lung NK cells expressed C-type lectin-like human leukocyte antigen (HLA)-E-specific inhibitory receptor (i.e. CD94/NKG2A), but only a few lung NK cells expressed killer cell immunoglobulin-like inhibitory receptors specific for HLA-A, -B or -C molecules. In addition, a significantly increased number of CD56+ T-cells were observed in the blood of patients when compared with controls. Upon in vitro stimulation, both lung NK and CD56+ T-cells produced considerable amounts of interferon-gamma and tumour necrosis factor-alpha. Thus, in the lungs of patients with pulmonary sarcoidosis, a distinct phenotype of natural killer cells with the capacity to produce cytokines and actively participate in the T-helper 1-like inflammatory response associated with sarcoidosis was identified.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bronchoalveolar Lavage Fluid / cytology*
  • CD56 Antigen / analysis
  • CD56 Antigen / genetics
  • CD56 Antigen / metabolism*
  • Case-Control Studies
  • Cells, Cultured
  • Female
  • Flow Cytometry
  • Humans
  • Inflammation Mediators / analysis
  • Inflammation Mediators / metabolism*
  • Killer Cells, Natural / metabolism*
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Phenotype
  • Prognosis
  • Reference Values
  • Risk Assessment
  • Sarcoidosis, Pulmonary / diagnosis*
  • Sarcoidosis, Pulmonary / metabolism
  • Sensitivity and Specificity
  • Severity of Illness Index
  • T-Lymphocytes / metabolism

Substances

  • CD56 Antigen
  • Inflammation Mediators